Peptide‐based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities
- 1 December 2001
- journal article
- review article
- Published by Wiley in Immunology
- Vol. 104 (4) , 367-376
- https://doi.org/10.1046/j.1365-2567.2001.01324.x
Abstract
No abstract availableThis publication has 106 references indexed in Scilit:
- SELECTION OF THE T CELL REPERTOIREAnnual Review of Immunology, 1999
- THE DYNAMICS OF T CELL RECEPTOR SIGNALING: Complex Orchestration and the Key Roles of Tempo and CooperationAnnual Review of Immunology, 1999
- MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic EnvironmentAnnual Review of Immunology, 1999
- Altered Peptide Ligands of Islet Autoantigen Imogen 38 Inhibit Antigen Specific T Cell Reactivity in Human Type-1 DiabetesJournal of Autoimmunity, 1998
- Myelin Basic Protein–specific T Helper 2 (Th2) Cells Cause Experimental Autoimmune Encephalomyelitis in Immunodeficient Hosts Rather than Protect Them from the DiseaseThe Journal of Experimental Medicine, 1997
- INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative ApproachesAnnual Review of Immunology, 1997
- Published by American Association for the Advancement of Science (AAAS) ,1994
- T Cell Deletion in High Antigen Dose Therapy of Autoimmune EncephalomyelitisScience, 1994
- Tickling the TCR: selective T-cell functions stimulated by altered peptide ligandsImmunology Today, 1993
- Dominance and Crypticity of T Cell Antigenic DeterminantsAnnual Review of Immunology, 1993